Evidence map›Paper›PMID 34400632›Full record

ArticleNature communications2021

Toward scalable biocatalytic conversion of 5-hydroxymethylfurfural by galactose oxidase using coordinated reaction and enzyme engineering.

William R Birmingham, Asbjørn Toftgaard Pedersen, Mafalda Dias Gomes, Mathias Bøje Madsen, Michael Breuer, John M Woodley, Nicholas J Turner

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 104 citations in OpenAlex.

  1. Article
  2. Article
  3. Crossing the Oxo-Peroxo Wall for Selective Electrochemical Epoxidation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Monitoring and control of the release of soluble OBiotechnology and bioengineering · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

William R BirminghamSchool of Chemistry, The University of Manchester, Manchester Institute of Biotechnology, Manchester, UK.ORCID 0000-0002-8880-5502
Asbjørn Toftgaard PedersenDepartment of Chemical and Biochemical Engineering, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0002-5283-3210
Mafalda Dias GomesDepartment of Chemical and Biochemical Engineering, Technical University of Denmark, Lyngby, Denmark.
Mathias Bøje MadsenDepartment of Chemical and Biochemical Engineering, Technical University of Denmark, Lyngby, Denmark.
Michael BreuerBASF SE, White Biotechnology Research, Ludwigshafen, Germany.
John M WoodleyDepartment of Chemical and Biochemical Engineering, Technical University of Denmark, Lyngby, Denmark.ORCID 0000-0002-7976-2483
Nicholas J TurnerSchool of Chemistry, The University of Manchester, Manchester Institute of Biotechnology, Manchester, UK. nicholas.turner@manchester.ac.uk.ORCID 0000-0002-8708-0781
Technical University of Denmark · DKUniversity of Manchester · GBBASF (Germany) · DENovozymes (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Hydroxymethylfurfural (HMF) has emerged as a crucial bio-based chemical building block in the drive towards developing materials from renewable resources, due to its direct preparation from sugars and its readily diversifiable scaffold. A key obstacle in transitioning to bio-based plastic production lies in meeting the necessary industrial production efficiency, particularly in the cost-effective conversion of HMF to valuable intermediates. Toward addressing the challenge of developing scalable technology for oxidizing crude HMF to more valuable chemicals, here we report coordinated reaction and enzyme engineering to provide a galactose oxidase (GOase) variant with remarkably high activity toward HMF, improved O

Indexed as

Protein EngineeringBiocatalysisCatalysisCatalytic DomainFuraldehydeFuransGalactose OxidaseMutagenesisOxidation-Reduction5-hydroxymethylfurfuralFuraldehydefuranFuransGalactose Oxidase

Identifiers

PMID34400632
PMCPMC8367993
OpenAlexW3196268500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.